Initial manifestations of memory loss, cognitive deficits and behavioral problems reveal neuronal distress in individuals with AD. Alterations of neuronal cytoskeleton proteins in neurofibrillary tangles (Hanger et al., 1991) , dystrophic neurites in senile plaques (Benes et al., 1991) , loss of synapse in the brain (Hamos et al., 1989) , and neuronal loss confirm this neuronal deterioration (Davies and Maloney 1976; Whitehouse et al., 1982; Terry et al., 1981) . Despite considerable progress in AD research, the cause of neuronal distress and death is not clear. Chromosomes 14, 19, and 21, are genetically linked to FAD (Hyslop 1987; Schellenberg et al., 1992; Nechiporuk et al., 1993) . The role of APP in FAD linked to chromosome 21 is highly supported by the identification of APP mutations and remains today our strongest link to understanding some of the molecular mechanisms of AD. Abundant amounts of the 40-43 amino acid AB (4 kDa AB), arising from the metabolism of APP a transmembrane glycoprotein, are deposited in the senile plaques and cerebrovascular tissues of AD brains (Glenner and Wong, 1984; Shoji et al., 1992; Busciglio et al., 1993) . The differentially spliced APP,,, form is the most highly expressed isoform of APP in brain and primary neuron cultures (Goedert, 1987; LeBlanc et al., 1991) . Metabolism of APP occurs through at least three pathways. The secretory pathway involves an a-secretase cleavage of APP within the AB domain thereby preventing the formation of 4 kDa AB, and generates a large secreted N-terminal peptide (sAPP) and a -10 kDa cell-associated C-terminal peptide which can be further processed into a secreted nonamyloidogenic 3 kDa AB peptide (Esch et al., 1990; Bhasin et al., 1991; Wang et al., 1991; Busciglio et al., 1993; Haass et al., 1993) . The endosomal-lysosomal system yields a series of five cellular APP C-terminal peptides in human brain, the largest and potentially amyloidogenic containing the full AB domain Golde et al., 1992; . A third pathway, involving endocytosis, generates secreted 4 kDa AB mostly composed of 40 amino acids (AB,-40) although lower levels of variants ranging from -6 to 42 or 43 amino acids exist (AB,.42,43) (Seubert et al., 1992; Shoji et al., 1992; Koo and Squazzo 1994; LeBlanc and Gambetti, 1994) . APP mutations at codon 717 Goate et al., 1991; Murell et al., 1991; Van Duijn et al., 1991) , and codon 670/671 in FAD Hendricks et al., 1992) as well as codon 692 in hereditary cerebral hemorrhage with amyloidosis of the Dutch type (HCHWAD) (Levy et al., 1990) , strongly support a primary role for APP in the pathogenesis of AD. Both APP670/671 and APP692 mutations produce excess AB,.40 in vitro and in vivo (Cai et al., 1993; Citron et al., 1992 Citron et al., , 1994 Haass et al., 1994; Nakamura et al., 1994) . The APP717 mutations increase the level of AP,.42,43 which, because of its higher hydrophobicity, may promote amyloid deposition (Jarrett et al., 1993 ; Suzuki et al., 1994; Tamaoka et al., 1994) . Overexpression of AP from APP717 mutant constructs in transgenic mice results in AP deposits with specific characteristics of senile plaque amyloid (Games et al., 199.5) . Thus, overexpression of AP appears to be an important factor in Al3 deposition in individuals carrying APP mutation.
The small amount of FAD individuals carrying APP mutations questions the etiology of AP in sporadic AD. Sporadic and FAD have similar pathology Lantos et al., 1992) . Despite the information gleaned from the APP mutations, it is still not clear whether AP deposition precedes neuritic problems (Martin et al., 1994) . Since AP induces apoptosis of rodent primary foetal hippocampal neurons and pancreatic islet cells (Yankner et al., 1990; Forloni et al., 1993; Loo et al., 1993; Lorenzo et al., 1994) , it is proposed that neuronal loss in AD could be a consequence of apoptosis (Su et al., 1994; Thompson 1994) . Apoptotic cell death entails a genetically programmed series of events which results in cell rounding, shrinkage and membrane blebbing, cytoskeletal reorganization, chromatine condensation and DNA fragmentation while retaining plasma membrane integrity and precluding an inflammatory response (Thompson, 1994; Tomei and Cope, 1991, 1994) . Since neuronal dysfunction and eventually cell death is common to sporadic and FAD, this study investigates APP metabolism in serum deprived human primary neurons which display the apoptotic phenotype. The results show that challenged neuron cultures generate three times more 4 kDa AP than healthy neurons while metabolism of APP through the nonamyloidogenic secretory pathway decreases twofold. The results show that increased AP can occur in neuron cultures deprived of essential survival factors and may provide a source for Al3 deposition in the absence of APP mutations.
Materials and Methods Primary neuron cultures
Neurons. The brain tissue from 14-18 week old human foetus was obtained according to the guidelines of the Medical Research Council of Canada, and was approved by McGill University Institutional Review Board. The isolation of neurons is a modification of methods published (Mattson and Rychlik, 1990; LeBlanc et al., 1991) and was set up in association with Dr. Cinthya Goodyer, Dr. Jack Antel, and Manon Blain from McGill University. Essentially, the cerebral tissue is minced in serum free neuronal media (MEM in Earle's balanced salt containing 0.225% sodium bicarbonate, 1 mM sodium pyruvate, 2 mM L-glutamine, 0.1% dextrose, 1 X antibiotic Pen-Strep; all products bought from GIB-CO-BRL, Ontario) and dissociated by trypsin treatment. The cells are plated at 3 X 10h cells/ml of 5% decomplemented serum containing media on poly-lysine coated dishes. After 4, 7, and 10 d in culture, 1 mM of the antimitotic agent, 5' fluoro-2'-deoxyuridine (FdU: Sigma, StLouis, MO), is added in fresh media (Martin et al., 1990) .
Astrocytes. The astrocytes were purified by differential shaking as described by LeBlanc et al. (1991) .
Characterization of cell types in the cultures
Immunofluorescence was carried out to determine the cellular composition of the FdU treated primary neuronal and astrocytic cultures after t 
Apoptosis of neuron cultures
Apoptosis was achieved by serum deprivation for various times, thereby removing essential growth factors to the FdU treated neurons. Staining of the condensed chromatine. Apoptotic nuclei were visualized with the DNA stain, propidium iodide. Serum deprived and control serum treated neuron cultures were permeabilized and fixed in acidalcohol before staining in 0.1 kg/ml propidium iodide (Sigma, St. Louis, MO) for 20 min in PBS. Apoptotic and normal nuclear DNA were detected by epifluorescence using a 40X objective. Propidium iodide homogeneously stains well-rounded nuclei in normal cells whereas clumped and broken chromatine is observed in irregularly shaped nuclei in apoptotic neurons. Approximately 500 neurons were scored per time point in three independent cell cultures.
LDH assay of neuronal media. The LDH was detected in the culture media from 'serum treated and deprived cultures using the Cytotox 96 calorimetric test as described by the manufacturer (Promega, Madison, WI).
DNA Zudder. Cells were lysed in 0.4% Triton X-100 in TE (10 mM Tris pH 8.0 and 1 mM EDTA) and treated 30 min at 37°C with 100 kg/ ml of RNase A followed by 100 pg/ml proteinase K at 56°C overnight. The DNA was phenol extracted and end labeled as described (Rosl 1992 ).
Metabolic labeling and assessing APP metabolism
Neurons were incubated in 250-500 pCi/ml translation grade ?Smethionine (NEN DuPont, Canada) in serum and methionine free DMEM containing 1 mM sodium pyruvate and 2 mu glutamine after an initial incubation in methionine-free media for an hour. To assess APP synthesis neurons were pulsed for 30, 60, and 120 min. To assess secretion of sAPP and degradation of APP, neurons were labeled for 60 min and chased in a 3000-fold excess cold methionine for 30, 60, 120, 240, and 360 min. Cells were labeled 5 hr for the detection of full length APP, C-terminal fragments and AB. The cells were lysed in NP-40 detergent lysis buffer and immunoprecipitations were carried out in RIPA buffer (Lane, 1989) Immunoprecipitations of APP and APP fragments were conducted with the following antibodies: anti-N against human sAPP,,, (kind gift from Barry Greenberg, Cephalon, Inc., PA), anti-C,,, monoclonal 6E10 and 4G8 against epitope 1-17 and 17-24 of AB, respectively (Kim et al., 1990a,b) and anti-1 antisera against amino acids 649-664 of APP,,, (kind gift from D. Selkoe, Harvard Medical School). Competition of anti-C,, and anti-Al3 immunoprecipitations was carried out with 1 )*g C,, and A@,,, peptides. Immunoprecipitates were electrophoresed on a three layer Tris Tricine polyacrylamide gel (16.5%, lo%, 4%) (Schagger and Von Jagow, 1987) then fixed, dried and exposed to x-ray film X-OMAT AR and phosphorimaging screen. Quantitation and statistical analysis of phosphorimaging data Quantitation of the immunoprecipitated fragments was done by phosphorimaging (Molecular Dynamics). Relative amounts of sAPP produced from serum deprived and serum treated cultures were calculated as a percentage of full length cellular APPs immunoprecipitated with anti-N. Relative amounts of AP produced from serum deprived and serum treated cultures were calculated as a percentage of full length secreted and cellular APPs immunoprecipitated with anti-N. The number of pixels obtained from quantitative phosphorimaging were corrected for the content in methionine of the measured APP or APP fragment and also corrected for the volume immunoprecipitated from the cellular lysate or secreted proteins. The amount of C-terminal fragments was calculated as a percentage of full length APP immunoprecipitated with anti-C,,. Absolute levels were not calculated because of the possible variations in the rate of 35-S methionine incorporation, amino acid pool size and number of cells synthesizing the APPs in serum deprived compared to control neuron cultures (Wiesner and Zak, 1991) . Rate of synthesis was calculated as the accumulation of APP with time. Rate of degradation was calculated during the exponential decay of cellular APP in the chase period (T,,, = ln2/K,; K, = (dP/dT)IP).
The significance of results from P serum deprived and serum treated neurons within a same experiment (identical cultures), were evaluated statistically by a paired two-tailed t test. Significance of results from independent experiments was determined by an unpaired two-tailed t test. Each set of data is the average of at least three independent experiments.
Results
To understand APP metabolism in healthy and serum deprived neurons, highly purified human primary neuron cultures were obtained from foetal brain tissue between 14 and 16 weeks of development. Human primary neuron cultures are ideal for these studies since AB deposits are fairly restricted to the brain of primates and bigger animals and is absent from the conventional rodent models. Treatment of mixed primary cultures with 1 mM fluorodeoxyuridine (FdU) generates neuronal cultures containing approximately 90% neurons by 7 d of treatment. The neurons are well differentiated and establish healthy networks of neurites under these conditions as shown under phase contrast and by tau immunostaining (Fig. lA-C ). Neurons were also immunostained with tau, MAP2 and neurofilament monoclonal antibody (not shown). GFAP-positive astrocytes (10.5% of the cells; SD of 3) remaining after FdU treatmebt are always in close association with the neurons (Fig. 1 B,D) . Few microglia, fibroblasts, or oligodendrocytes (<0.5%) were detected by LDL-DiI incorporation, anti-fibronectin and anti-galactocerebroside antibodies, respectively (not shown).
Serum deprivation was used to remove essential growth factors to the neurons and therefore initiate the apoptotic mechanism of cellular death. Cell morphology, chromatine condensation and DNA fragmentation were assessed at various times after serum deprivation. Phase contrast micrographs of serum deprived neurons show obvious shrinkage and rounding of the neuronal cell body, a typical feature of apoptotic cells, (Tomei and Cope, 1991) as well as loss of neuritic integrity manifested by neurite bubbling, breakage and retraction ( Fig. 2A) . In contrast, serum treated neurons display larger cell bodies and entertain a healthy neuritic network. Chromatine condensation was detected by irregularly shaped dense nuclear masses brightly stained by propidium iodide as opposed to homogeneous staining of the normal nuclear DNA. Double staining with a polyclonal tau/ MAP antibody revealed that only neurons undergo apoptosis, not astrocytes (not shown). The percentage of apoptotic neurons in serum deprived cultures at various time points was calculated by counting the number of condensed chromatine, tauNAP positive neuronal cells as a percent of total neurons in at least three independent experiments. The percentage of apoptotic neurons is 14% after 12 hr of serum deprivation and increases slightly between 12 and 36 hr. Between 36 and 48 hr of serum deprivation, a sharp increase to 68% of apoptotic neurons is observed. At 48 hr, approximately 10% of the cells have floated off the attachment matrix and this value may be an underestimation of the actual numbers of apoptotic neurons. By 72 hr of serum deprivation few healthy neurons remain (< 10%) (Fig. 2B) . Preliminary studies to determine the commitment time of the neurons to apoptosis indicates that reversal of apoptosis can be achieved before 12 hr of serum deprivation by adding serum to the culture but not after 12 hr. The variability in numbers of apoptotic neurons between isolated cultures as denoted by the high standard deviation (Fig. 2B) is consistent with that observed in other primary neuron culture systems (Edwards and Tolkovsky, 1994) . To determine the presence of DNA fragmentation, DNA was extracted from 12 and 24 hr serum deprived neurons. Because of the limitation in neuron numbers for the experiments, end labeling with '*P-dCTP allowed visualization of DNA fragments in expected sizes of 180 bp and multiples thereof (Wyllie, 1980) (Fig. 2C) . Therefore, identification of rounded, shrunken neurons containing condensed nuclear chromatine and the presence of DNA fragments in the neuronal cultures confirms the apoptotic nature of the neurons (Fig. 2C) . To evaluate the possibility that serum deprivation causes cell death by necrosis in these same cultures, LDH release was measured in the serum deprived neuron culture media (Fig. 20) . LDH levels remained stable for up to 72 hr of serum deprivation increasing slightly between 72 and 96 hr. In control neuronal cultures, LDH levels remained constant although much higher than in serum deprived cultures because of the presence of LDH in serum which turns out to be very useful as a positive control for the LDH assay. These results indicate that little necrotic cell death occurs between 12 and 72 hr of serum deprivation. We are presently investigating in more details, the molecular mechanisms of apoptotic cell death in human neurons with this model.
To capture APP synthesis before abundant neuronal cell death occurs but in cells committed to apoptosis, the 12 hr time point of serum deprivation was chosen for the following experiments on APP synthesis, degradation, and metabolism. To compare APP isoforms and detect major shifts in quantitative expression of APP in serum deprived compared to serum treated neurons, cultures treated for 12 hr were metabolically labeled for 5 hr and the proteins immunoprecipitated with antibodies directed against various epitopes of APP (Fig. 3A) . Metabolic labeling of cells requires serum free conditions which include one hour starvation of the cells in methionine/serum free media before labelling. Therefore, in this experiment, the control serum treated cells were 6 hr without serum whereas serum deprived cells were 18 hr without serum. The full length APP analyzed in this figure is that accumulated within the cells during the 5 hr labeling period following the 1 hr methionine starvation period. In normal cultures, anti-C,, and anti-N antiserum immunoprecipitate three major proteins of 95-125 kDa (Fig. 3B) . Anti-C,, immunoprecipitated proteins were completely competed out with C,, peptide (C21+). These likely represent full length immature and mature APPs. The size is consistent with APP,,,, the major APP isoform in neurons. To check for the possible presence of APP-like proteins (APLPs) which do not contain the AB domain (Wasco et al., 1993) , immunoprecipitation was carried out with the 4G8 antibody which recognizes amino acids 17-24 of the AB domain. The same three major APPs were immunoprecipitated with the 4G8 antibody. Similarly, the anti-1 antisera against amino acids 649-664 of APP immunoprecipitates these same three proteins (lane I). Therefore, the three major proteins immunoprecipitated with anti-N, anti-C, 4G8 and anti-1 are APPs. A fourth APP protein migrating below immature fulllength APP is obvious in the anti-N but not anti-C,, immunoprecipitation.
To further characterize this protein, APLPs and APPs were first immunoprecipitated with anti-C,, antisera and the remaining proteins reimmunoprecipitated with anti-N antisera (lane C21/N). A considerable amount of the lower MW APP was immunoprecipitated.
This protein was not immunoprecipitated with 4G8, anti-1 (Fig. 3B) or 6ElO (not shown) and likely represents the truncated N-terminal APP fragment resulting from p-secretase cleavage of APP (Seubert et al., 1993) . The APPs in serum deprived neurons did not differ qualitatively from those of control serum treated neurons.
To examine the synthesis and degradation of APPs in serum treated and serum deprived cultures, pulse chase experiments were carried out (Fig. 3C) . After metabolic labeling of the culture for 30, 60, and 120 min, the rate of APP synthesis was assessed by phosphorimaging quantitation of immunoprecipitated full length APPs at these time points. An average of three independent experiments shows that the rate of APP synthesis decreases threefold (2.98 + 0.5) in serum deprived neurons. Since no notable difference is observed in the steady state of newly synthesized APPs in serum deprived and control neuron cultures (Fig. 3B) , the APP degradation was assessed by 35S-methionine labeling for 60 min followed by a chase at various time points in cold methionine containing media. The APP halflife, assessed during the exponential decay of the APP during the chase, was 317 -+ 14 min in serum deprived neurons but only 223 ? 25 min in control neurons (Fig. 30) . Therefore, the longer half-life in serum deprived neurons should compensate partially for the decreased rate of APP synthesis observed.
To determine if one particular APP metabolic pathway is affected in serum deprived neuron primary cultures, the amount of sAPP, C-terminal fragments and A@ peptides were assessed as markers of the secretory, lysosomal-endosomal and 4 kDa AP-producing pathways, respectively. Metabolism of APP through the secretory pathway was determined from a pulse chase experimental paradigm. Neurons deprived of serum for 12 hr and control serum treated neuron cultures were both starved in serum and methionine free media for 1 hr before labeling with 35-S methionine for 1 hr. After 1 hr of labeling, the proteins were chased with methionine containing media. During the pulse chase experiment, the amount of sAPP from serum deprived neurons after 4 hr of chase was only 20% of the newly synthesized APP compared to 40% in normal neurons (Fig. 4A) . Thus, decreased metabolism of APPs through the non-amyloidogenic secretory pathway leaves 20% more APP to be metabolized through either of the two amyloidogenic pathways. Metabolism of APP through the endosomal-lysosomal pathway was assessed in neurons labelled for 5 hr. Five APP C-terminal fragments were immunoprecipitated with the anti-C,, antisera and fully competed by the addition of C,, peptide (C21+) during the immunoprecipitation (Fig. 4B) . The four larger fragments were also immunoprecipitated with the 4G8 monoclonal antisera indicating that the fragments contain at least part of the AP domain. Only the largest C-terminal fragment was immunoprecipitated with 6ElO indicating that the top C-terminal fragment contains the entire AP domain (not shown). Phosphorimaging quantitation shows that the second and fourth largest C-terminal fragments (C2 and C4) represent 0.52% and 0.48% of full length APP immunoprecipitated with anti-C,, and C5, Cl, and C3 represent 0.42%, 0.32% and 0.29%, respectively (Table 1) . The amount of C-terminal fragments in serum deprived neurons were not significantly different from control cultures. Therefore, serum deprived neurons do not produce excess potentially amyloidogenic C-terminal fragments.
To assess AP production, neurons serum deprived for 12 hr and controls were labeled 5 hr. Full length APP and AP were immunoprecipitated with anti-N and 4G8. The monoclonal 4G8 antibody immunoprecipitates three AP peptides from the secreted proteins of neuron cultures (Fig. 4C) . These peptides were fully competed by addition of synthetic AP peptide (4G8+) in the immunoprecipitation.
The higher MW and most abundant AP peptide likely represents 4 kDa AP since it is also immunoprecipitated with 6ElO which recognizes amino acids 1-17 of AP (Fig. 4C ). The two lower bands which are not immunoprecipitated with 6E10, likely represent the non-amyloidogenic 3 kDa A@ (Haass et al., 1993) . The amount of 4 kDa AP generated in 5 hr of 35S-methionine labeling appeared to be higher in neurons serum deprived for 12 hr before labeling (Fig. 4C) . Immunoprecipitation of cellular APP holoprotein with 4G8 confirms the integrity of the antibody in this immunoprecipitation. Since the rate of translation of newly synthesized APP is lower in serum deprived neurons than in controls, the amount of AP was calculated as a percentage of full length cellular APP immunoprecipitated with anti-N after 5 hr labeling. Phosphorimaging quantitation of five independent experiments shows a threeto fourfold increase in 4 kDa AP production in serum deprived cultures (Fig. 40) . Similar results were obtained when AP was measured as a percentage of APP immunoprecipitated with anti-C,, (not shown). To assess the specificity of the increased prot duction of 4 kDa A& the production of the 3 kDa A@ was also measured as a proportion of full length APl? The amount of the 3 kDa A@ referred to as <4kDa A@ are equivalent in serum deprived and normal cultures (Fig. 4E) . Therefore, metabolism of newly synthesized APP through the 4 kDa AP-producing pathway is increased three fold in serum deprived neural cultures. Since 10% of the neuronal cultures are astrocytes, the possibility that serum deprived neurons may signal astrocytes to overproduce AP or that serum deprived astrocytes generate excess AP was tested. Treatment of astrocytes for 12 hr with serum deprived neuron conditioned media of 12 hr failed to induce AP production in normal astrocytes (Fig. 4F) . Thus, it is unlikely that apoptotic neurons mediate increased AP production from astrocytes through secreted factors. Astrocyte cultures of over 99% purity were submitted to serum deprivation for 12 hr and radiolabeled for 5 hr in a manner identical to the neuron radiolabeling.
These astrocytcs did not generate more 4 kDa AP than normal astrocytes (Fig. 4F) . Therefore, the contaminating astrocytes of the neuronal cultures do not generate the threefold increase in 4 kDa AP observed during serum deprivation.
Discussion
In this study, APP metabolism in healthy and serum deprived human primary neuron cultures was investigated. A threefold increase in the production of 4 kDa AP in human primary neuron cultures submitted to serum deprivation for 12 hr is shown. The increased AP production is accompanied by decreased metabolism of the APP through the non-amyloidogenic secretory pathway while metabolism through the endosomal lysosomal pathway remains constant. Furthermore, the neurons submitted to serum deprivation undergo apbptosis thereby suggesting the possible influence of a dying neuron on overproduction of AP. localized to chromosome 21 which has been linked to FAD (Hyslop 1987; Patterson et al., 1988) . Second, the proteolytic product of APP, the AB, is abundant in two main lesions of AD brains; the senile plaque and cerebrovascular amyloid deposits (Glenner and Wong, 1984; Masters et al., 1985) . Third, mutations of APP associated with FAD generate excess A/3 (Citron et al., 1992 (Citron et al., , 1994 Cai et al., 1993; Suzuki et al., 1994; Tamaoka et al., 1994) . Fourth, trisomy 21 individuals have increased APP expression and develop AD pathology with age (Wisniewski et al., 1985; Tanzi et al., 1987) . Fifth, transgenic mice overexpressing mutant APP717 develop AB deposits, synaptic loss, neuritic plaques, and gliosis (Games et al., 1995) . Despite considerable research on the three pathways of APP metabolism; the secretory, the endosomal lysosomal, and the 4 kDa AB producing pathways, little is known on APP metabolism in the human neuron. Since naturally occurring AD pathogenesis is fairly limited to primate brain where APP is highly expressed particularly in neurons (Goedert, 1987; Benowitz et al., 1989; LeBlanc et al., 1991) , the present study in human primary neuron cultures addresses an important aspect to understand APP metabolism in humans and can offer a more direct correlation with AD. The results show selective expression of APP,,, in human neurons. The 40% secretion of newly synthesized APP in normal neurons agrees with levels detected in human CSF and brain (Palmert et al., 1989 , Pasternack et al., 1992 . The five C-terminal fragments described in human brain (Cl to C5) and arising from the endosomal-lysosomal pathway ) represent a significant fraction of the APP fragments in neuron cells. The immunoreactivity of the four larger C-terminal fragments agree with the sequence obtained from APP,,,-transfected neuroblastoma cells, the largest only (Cl) being capable of further processing to 4 kDa AB . However, whereas equivalent levels of all five fragments were reported in human brain, in neuron cultures, an order of decreasing abundance from C4, C2, C5, Cl, and C3 is clear. The relative abundance of these C-terminal fragments in human neurons suggest that either the metabolism of APP through the endosomal-lysosomal pathway is prominent in human neurons or the C-terminal fragments have a longer half-life. The amyloidogenic nature of human neuron APP metabolism is further supported by greater 4 kDa AB than 3 kDa AB levels as previously observed (Busciglio et al., 1993) .
Effect of serum deprivation on APP metabolism in human primary neuron cultures APP metabolic studies in primary human neuron cultures deprived of serum for 12 hr agree with the hypothesis that decreased APP metabolism through the nonamyloidogenic secretory pathway provides more APP for the two amyloidogenic pathways. As APP secretion is decreased twofold in serum deprived neurons, 4 kDa AB increases threefold compared to control cultures. Serum deprivation of the primary neuronal cultures also has an effect on APP synthesis and degradation. APP synthesis is decreased 3-fold while APP half-life increases by 1.5-fold. One may wonder whether the absolute increase in 4 kDa AB is significant since de novo APP synthesis is decreased. However, it is likely that the unlabeled pool of APP holoprotein in serum deprived and control cultures will be metabolized the same way as the labeled pool. Since the pools of unlabeled APP should be identical at the beginning of the experiment, increased AB from the unlabeled APP pool should also occur in serum deprived neurons compared to control.
Is there a link between neuronal apoptosis, increased 4 kDa AP production and decreased sAPP? Apoptotic primary neurons have been extensively described in NGF deprived rat sympathetic cervical ganglion cells (Edwards et al., 1991; Martin et al., 1992; Edwards and Tolkovsky 1994; Estus et al., 1994) . The neurons undergo initial decreased protein synthesis, cell shrinkage and rounding, membrane blebbing and the appearance of condensed chromatine denotes a commitment of the neurons to apoptosis Deckwerth and Johnson 1993; Edwards and Tolkovsky, 1994) . Although the human primary neuron culture has to be further defined, apoptosis definitely occurs in serum deprived cultures which also shows neurons with cell rounding and shrinkage, definite condensed nuclear chromatine and fragmented DNA which appears as early as 12 hr of serum deprivation (Fig. 2) . Since serum deprived astrocytes fail to undergo apoptosis and secrete normal levels of 4 kDa A@, it is likely that the altered production of AB in serum deprived neurons is related to neurons undergoing apoptosis.
The reason for decreased secretion of APP in serum deprived neuronal cultures is not clear. Increased secretion of APP is regulated by protein kinase C activation either through direct activation by phorbol esters (Buxbaum et al., 1990; Caporaso et al., 1992; Gillespie et al., 1992; Slack et al., 1993) or through stimulation of receptors linked to protein kinase C (Nitsch et al., 1992; Buxbaum et al., 1993) . Therefore, decreased sAPP in serum deprived neurons may result from the removal of protein kinase C activating factors normally present in serum. However, while repression of protein kinase C activity inhibits receptor activated APP secretion (Nitsch et al., 1992) it also activates apoptosis (Walker et al., 1993; Jacobson et al., 1994) . Thus, decreased secretion of sAPP could be a consequence of apoptosis.
Possible implications jtir sporadic AD Increased 4 kDa AB production in serum deprived neuron cultures supports a novel hypothesis explaining AB deposits in the brain of sporadic AD individuals. Focally increased AB from a dying neuron could engender further neurodegeneration of neighboring neurons. The lesser frequency of neurons dying in a younger versus an aging brain could explain the later manifestation of the disease in sporadic AD. In contrast, increased AB either as the result of APP gene mutations or increased APP gene expression could be the initiator of apoptosis in FAD.
